Home / Pharma news / US FDA approves Novartis’ Rydapt

US FDA approves Novartis’ Rydapt

The US Food and Drug Administration (FDA) has approved Novartis’ Rydapt (midostaurin, formerly PKC412) for two indications.

Read more @ http://www.pharmabiz.com/NewsDetails.aspx?aid=101706&sid=2

Check Also

Diabetes-Silent Killer

The total estimated cost of diagnosed diabetes in 2017 was $327 billion, including $237 billion ...

%d bloggers like this: